DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

• Atish Kizhakeyil,
• Nurmahirah Binte Mohammed Zaini,
• Zhi Sheng Poh,
• Brandon Han Siang Wong,
• Xinpeng Loh,
• Aik Seng Ng,
• Zun Siong Low,
• Praseetha Prasannan,
• Chun Gong,
• Michelle Guet Khim Tan,
• Chandramouli Nagarajan,
• Dachuan Huang,
• Pang Wan Lu,
• Jing Quan Lim,
• Sharon Barrans,
• Choon Kiat Ong,
• Soon Thye Lim,
• Wee Joo Chng,
• George Follows,
• Daniel J. Hodson,
• Ming Qing Du,
• Yeow Tee Goh,
• Suat Hoon Tan,
• Nicholas Francis Grigoropoulos,
• Navin Kumar Verma

Affiliations

Atish Kizhakeyil

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore

Nurmahirah Binte Mohammed Zaini

Department of Haematology, Singapore General Hospital, The Academia

Zhi Sheng Poh

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore

Brandon Han Siang Wong

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore

Xinpeng Loh

School of Biological Sciences, Nanyang Technological University Singapore

Aik Seng Ng

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore

Zun Siong Low

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore

Praseetha Prasannan

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore

Chun Gong

Wellcome MRC Cambridge Stem Cell Institute

Michelle Guet Khim Tan

Clinical Translational Sciences, Singapore General Hospital

Chandramouli Nagarajan

Department of Haematology, Singapore General Hospital, The Academia

Dachuan Huang

Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore

Pang Wan Lu

Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore

Jing Quan Lim

Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore

Sharon Barrans

Haematological Malignancy Diagnostic Service (HMDS), St. James’s Institute of Oncology

Choon Kiat Ong

Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore

Soon Thye Lim

Director’s office, National Cancer Centre Singapore

Wee Joo Chng

National University Cancer Institute

George Follows

Addenbrooke’s Hospital NHS Foundation Trust

Daniel J. Hodson

Wellcome MRC Cambridge Stem Cell Institute

Ming Qing Du

Department of Pathology, University of Cambridge

Yeow Tee Goh

Department of Haematology, Singapore General Hospital, The Academia

Suat Hoon Tan

National Skin Centre Singapore

Nicholas Francis Grigoropoulos

Department of Haematology, Singapore General Hospital, The Academia

Navin Kumar Verma

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore